Home > Income Statement > NGL FINECHEM

NGL FINECHEM
Revenue

    Back to Income Statement
NGL FINECHEM is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹339 Cr₹278 Cr₹318 Cr₹258 Cr₹152 Cr

What is the latest Revenue of NGL FINECHEM ?

The latest Revenue ratio of NGL FINECHEM is ₹339 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹339 Cr
Mar2023₹278 Cr
Mar2022₹318 Cr
Mar2021₹258 Cr
Mar2020₹152 Cr

How is Revenue of NGL FINECHEM Trending?

Years Revenue % Change
Mar2024 ₹339 Cr
21.79
Mar2023 ₹278 Cr
-12.42
Mar2022 ₹318 Cr
23.08
Mar2021 ₹258 Cr
70.07
Mar2020 ₹152 Cr -

Compare Revenue of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹682.7 Cr -0.9% 1.9% -51% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,971.0 Cr -7.3% 1.1% 15.2% Stock Analytics
DIVIS LABORATORIES ₹161,153.0 Cr -3.5% 12.9% 53.4% Stock Analytics
CIPLA ₹122,717.0 Cr 0.1% 9.2% 6.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,392.0 Cr -1% 0.2% 19.9% Stock Analytics
DR REDDYS LABORATORIES ₹100,702.0 Cr 3.1% 9.8% -7.6% Stock Analytics


NGL FINECHEM Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

-0.9%

1.9%

-51%

SENSEX

0.6%

11%

10.4%


You may also like the below Video Courses